Balyasny Asset Management L.P.

Position in SLDB — Solid Biosciences Inc.

CIK 1218710 Chicago, IL

Position in SLDB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,780,747

+$497,326 QoQ

Shares Held

178,253

0.0% QoQ

Ownership

0.166%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 156 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. SLDB ranks #106 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,780,747	178,253	0.0%	Shares	Sole	2026-08-14
2026-03-31	$1,283,421	178,253	-50.6%	Shares	Sole	2026-05-15
2025-12-31	$2,035,684	360,937	-50.7%	Shares	Sole	2026-02-17
2025-09-30	$4,520,191	732,608	+50.4%	Shares	Sole	2025-11-14
2025-06-30	$2,372,289	487,123	-22.3%	Shares	Sole	2025-08-14
2025-03-31	$2,320,913	627,274	+164.7%	Shares	Sole	2025-05-15
2024-09-30	$1,651,485	236,942	+907.2%	Shares	Sole	2024-11-14
2024-03-31	$313,353	23,525	-20.9%	Shares	Sole	2024-05-13
2022-09-30	$13,884	29,731	+156.3%	Shares	Sole	2022-11-15
2022-06-30	$7,144	11,598	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.